Disposable blood bags are used for collection, storage, transportation, and transfusion of human blood and blood components. These bags are manufactured from bio-compatible PVC, compounded with suitable additives, which is not reactive to blood components. Disposable blood bags require the use of glass bottles as glass bottles require thorough cleaning, rinsing, and autoclaving procedures as well as there are chances of its breakage at any stage. Furthermore, the possibility of disposable bags eliminates the possibility of any contamination.
Disposable Blood Bags Market Dynamics
Prevalence of blood related disorders and requiring blood transfusion. Blood transfusion is commonly used for supportive care in transplant surgery, cardiovascular surgery, massive trauma, and haematological therapy. According to New York Blood Center (NYBC) 2018 data, car accident and trauma victims may need more than 50 red cell transfusions during the entire treatment process.
Click To Continue Reading On Disposable Blood Bags Market
Moreover, growing aging population, rising health issues and increasing awareness for blood donation are major factors driving growth of the disposable blood bags market. For instance, according to the WHO report of 2016, approximately 112.5 million units of donated blood are collected annually worldwide. All these factors are expected to give significant thrust to the size of the globally disposable blood bags market. However, huge shortfall in blood supplies in low-income countries due to lack of a robust infrastructure for blood collection, distribution, and storage is hampering the disposable blood bag market. In emerging economies, it is usually used to treat pregnancy complications and childhood anemia. According to Safe Blood for Africa,
Disposable Blood Bags Market Growth Drivers
Rising prevalence of diseases such as cancer and various blood related disorders (anemia, hemophilia, and sickle cell disease) is increasing demand for blood transfusion. For instance, about 90,000 to 100,000 people in the US and about 1,000 babies are born with the disease each year. Sickle cell patients often require blood transfusions throughout their lives.
The increasing number of cancer incidences worldwide is thus a major factor driving the disposable blood bag market’s growth. For instance, according to American Cancer Society, 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the US by the end of 2018. Majority of these patients is in need of blood, sometimes daily, during chemotherapy treatment. Furthermore, according to the New York Blood Center, approximately 4.5 million Americans receive blood transfusions each year and 40,000 pints are transfused each day in the country, to save the lives of cancer patients, burn, accident, and trauma victims, mothers delivering babies, Newborn babies, transplant patients, surgery patients and others in need.
Disposable Blood Bags Market – Regional Insights
On the basis of region, the global disposable blood bags market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In 2026, North America is expected to hold the leading position in the globally disposable blood bag market, owing to well-established and timely blood transfusion services. Growing awareness among people for blood donation is also a major factor driving the disposable blood bag market. According to the Red Cross Blood Organization, an estimated 6.8 million people donate blood every year.
Asia Pacific disposable blood bags market is expected to grow at the highest rate due to high demand for blood collection bags in the region. Growing healthcare facilities wants to act as a driver for growth of medical sector in countries such as India. In the region is expected to boost the disposable blood bags market in the near future.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2170
Key vendors:
AdvacarePharma, Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly Medicure, SURU International, Span Healthcare, and TERUMO PENPOL.